GLP-1 Resistance: What to Do When the Medication Isn't Working

You've been on a GLP-1 medication for months. You followed the titration schedule. You adjusted your diet. But the scale isn't moving — or it stopped moving much sooner than expected. You're not alone, and the problem may not be anything you're doing wrong.

In April 2026, researchers at Stanford Medicine published a study revealing that roughly 10% of the general population carries genetic variants that reduce the effectiveness of GLP-1 medications. This phenomenon is called GLP-1 resistance, and it's the first time science has begun to explain why some patients don't respond to these drugs the way clinical trials suggest they should.

What Is GLP-1 Resistance?

GLP-1 resistance occurs when your body produces GLP-1 hormone at normal or even elevated levels, but the hormone is less biologically active than it should be. In other words, you have more GLP-1 floating around, but it's not doing its full job.

The Stanford study identified the culprit: variants in a gene called PAM (peptidyl-glycine alpha-amidating monooxygenase). PAM is an enzyme responsible for activating many hormones in the body, including GLP-1. When PAM doesn't work properly, GLP-1 is produced but not fully activated — meaning you need more of it to achieve the same effect.

"In some of the trials, we saw that individuals who had those variants were unable to lower their blood glucose levels as effectively after six months of treatment." — Dr. Anna Gloyn, Stanford Medicine

Does GLP-1 Resistance Affect Weight Loss?

The Stanford study focused primarily on blood sugar regulation, not weight loss. Only two of the clinical trials analyzed provided weight data, and those showed no significant difference in weight loss between people with and without PAM variants. However, the researchers were clear that the data is too limited to draw conclusions about weight loss specifically.

Separately, a 23andMe Research Institute study published in April 2026 — involving over 27,000 participants — identified genetic variants in the GLP1R gene (the GLP-1 receptor itself) that are associated with both efficacy and side effects:

• Variants in GLP1R were linked to differences in weight loss response to GLP-1 medications
• Variants in GIPR were linked to nausea and vomiting — but only in patients taking tirzepatide (Mounjaro/Zepbound), not semaglutide (Ozempic/Wegovy)

This means genetics may influence both how well you respond and how badly you tolerate these medications.

Genetic Testing: Should You Get It?

Two companies — PrecisionLife and Ovation.io — announced plans in April 2026 to launch both direct-to-consumer and laboratory-developed genetic tests that predict GLP-1 response. These tests aren't widely available yet, but they're expected to reach the market later this year.

When they become available, testing may make sense if you:

• Have been on a GLP-1 for 3+ months with minimal response
• Have a family history of poor response to diabetes or weight loss medications
• Want to choose between semaglutide and tirzepatide based on likely side effects
• Are starting GLP-1 therapy for the first time and want to make an informed choice

For most first-time patients, testing probably isn't necessary. The majority of people do respond to GLP-1 medications, and a trial period of the medication itself is often the most practical "test." But if you've plateaued early or had an unusually poor response, genetic testing could provide useful data for your next clinical conversation.

Before Blaming Genetics: Rule These Out First

GLP-1 resistance is real, but it's rare (affecting ~10% of people). Before concluding you're genetically resistant, work through this checklist with your doctor:

1. Is Your Dose High Enough?

Many patients plateau because they haven't reached a therapeutic dose. Weight loss typically accelerates at moderate-to-high doses (1.0mg+ for semaglutide, 5.0mg+ for tirzepatide). If you're still on a starter dose, be patient — titration takes time.

2. Are You Taking the Medication Correctly?

For oral GLP-1s (especially oral Wegovy), dosing errors are common. Oral Wegovy must be taken on an empty stomach with minimal water. Taking it with food dramatically reduces absorption. Foundayo doesn't have this issue.

3. Are Other Medications Interfering?

Some medications can counteract GLP-1 effects. Beta-blockers, certain antidepressants, corticosteroids, and insulin can all affect weight independently. Review your full medication list with your doctor.

4. Are You Experiencing Hidden Caloric Compensation?

GLP-1s reduce appetite, but some patients unconsciously compensate by choosing calorie-dense foods when they do eat. A brief food journal can reveal patterns you might not notice otherwise.

5. Has Your Doctor Checked Your Thyroid?

Hypothyroidism can make weight loss difficult regardless of medication. A simple TSH blood test can rule this out.

What to Do If You're a Non-Responder

If you've ruled out the above and you're still not responding after 12–16 weeks at a therapeutic dose, talk to your doctor about these options:

• Switch medications: If semaglutide isn't working, tirzepatide (a dual GLP-1/GIP agonist) uses a different mechanism and may produce better results
• Try a different format: Some patients respond differently to oral vs. injectable formulations due to absorption differences
• Consider combination therapy: Your doctor may recommend adding metformin, a SGLT2 inhibitor, or other medications alongside your GLP-1
• Get genetic testing: When available, a pharmacogenomic test can help identify whether you carry PAM or GLP1R variants
• Request comprehensive labs: A1C, insulin levels, thyroid panel, cortisol, and liver function tests can reveal underlying issues

The Future of Personalized GLP-1 Treatment

We're entering an era where "try it and see" is being supplemented by data-driven prescribing. The Stanford and 23andMe research represent the first wave of pharmacogenomics applied to GLP-1 medications — and within a few years, it's likely that genetic testing will become a routine part of the initial GLP-1 consultation.

For now, the most important thing is to not give up too quickly. Work with your doctor to rule out treatable causes, ensure you're on the right dose and medication, and if all else fails, ask about the emerging genetic testing options. The goal isn't just to lose weight — it's to find the approach that works for your specific biology.